Literature DB >> 21275809

Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals.

Mie Hessellund Samson1, Ponlatham Chaiyarit, Helene Nortvig, Else Marie Vestergaard, Erik Ernst, Ebba Nexo.   

Abstract

BACKGROUND: Trefoil peptides are 7-12 kDa molecules, se-creted by a variety of mucin-producing epithelial cells from different tissues and believed to be essential for protection and maintenance of gastrointestinal mucosa. Data on concentrations of trefoil peptides in secretions are limited.
METHODS: We validated in-house ELISA assays, developed for measurement of trefoil peptide concentrations (TFF1, TFF2 and TFF3) in serum, for use with saliva and cervical mucus. Saliva from healthy individuals (n=30), and cervical mucus as well as blood collected three times during the menstrual cycle from healthy women (n=18) were analyzed.
RESULTS: Recovery of all trefoil peptides in the initial supernatants of saliva and (cervical mucus) were 86 and (92)% or more. Recovery of exogenously added trefoil peptides was 93 and (95)% or more. Western blotting showed that antibodies used in the TFF3-ELISA assay recognised one molecule of the same size as TFF3 in both saliva and cervical mucus. Median concentrations of TFF1, TFF2 and TFF3 in saliva and (cervical mucus) were 2.7 (2.7), 0.08 (0.58) and 14 (430) nmol/g protein, with a significant decrease in concentrations in cervical mucus after ovulation. Serum concentrations resembled previously measured values in blood donors and showed no cyclic change.
CONCLUSIONS: Previously established ELISA assays can be employed for measurement of trefoil peptides in saliva and cervical mucus. TFF3 was the predominant trefoil peptide in both saliva and cervical mucus, and TFF3 in cervical mucus represents the highest concentration measured in a biological fluid to date.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21275809     DOI: 10.1515/CCLM.2011.123

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  12 in total

1.  Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma.

Authors:  Ponlatham Chaiyarit; Akasith Utrawichian; Chanvit Leelayuwat; Patrawut Vatanasapt; Nattharee Chanchareonsook; Mie Hessellund Samson; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2011-12-30       Impact factor: 3.573

2.  Increased immunoexpression of trefoil factors in salivary gland tumors.

Authors:  Ponlatham Chaiyarit; Poramaporn Klanrit; Pensri Photipakdee; Ajiravudh Subarnbhesaj; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2014-05       Impact factor: 3.573

3.  Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study.

Authors:  Hasan Turan; Salvatore Giovanni Vitale; Ilker Kahramanoglu; Luigi Della Corte; Pierluigi Giampaolino; Asli Azemi; Sinem Durmus; Veysel Sal; Nedim Tokgozoglu; Tugan Bese; Macit Arvas; Fuat Demirkiran; Remise Gelisgen; Sennur Ilvan; Hafize Uzun
Journal:  Arch Gynecol Obstet       Date:  2022-04-24       Impact factor: 2.344

Review 4.  Acupuncture for Female Infertility: Discussion on Action Mechanism and Application.

Authors:  Jing-Yu Xu; An-Lan Zhao; Ping Xin; Jun-Ze Geng; Bao-Juan Wang; Tian Xia
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-04       Impact factor: 2.650

5.  Proteolytic effects of gingipains on trefoil factor family peptides.

Authors:  Ponlatham Chaiyarit; Janthima Jaresitthikunchai; Narumon Phaonakrop; Sittiruk Roytrakul; Barbara Potempa; Jan Potempa
Journal:  Clin Oral Investig       Date:  2017-07-19       Impact factor: 3.573

6.  TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.

Authors:  Felicity E B May; Bruce R Westley
Journal:  Endocr Relat Cancer       Date:  2015-04-21       Impact factor: 5.678

7.  Prolonged Suppressive Effects of Periodontitis on Salivary TFF3 Production.

Authors:  Doosadee Hormdee; Saengsome Prajaneh; Amonrujee Kampichai; Ranuch Tak; Ponlatham Chaiyarit
Journal:  Eur J Dent       Date:  2019-08-29

8.  Obstructive sleep apnea and rhonchopathy are associated with downregulation of trefoil factor family peptide 3 (TFF3)-Implications of changes in oral mucus composition.

Authors:  Regina Siber-Hoogeboom; Martin Schicht; Sebastian Hoogeboom; Friedrich Paulsen; Maximilian Traxdorf
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

9.  Effect of Initial Periodontal Therapy on Salivary Trefoil Factor (TFF3) in otherwise Healthy Patients with Gingivitis and Chronic Periodontitis.

Authors:  Devika Meesala; Gautami S Penmetsa; C D Dwarakanath; Ravikanth Manyam
Journal:  Contemp Clin Dent       Date:  2018-06

10.  Production of Monoclonal Antibodies against Human Trefoil Factor 3 and Development of a Modified-Sandwich ELISA for Detection of Trefoil Factor 3 Homodimer in Saliva.

Authors:  Saichit Khummuang; Waraporn Phanphrom; Witida Laopajon; Watchara Kasinrerk; Ponlatham Chaiyarit; Supansa Pata
Journal:  Biol Proced Online       Date:  2017-11-08       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.